Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors

被引:48
作者
Zoete, V
Michielin, O
Karplus, M
机构
[1] Univ Strasbourg 1, Lab Chim Biophys, Inst Sci & Ingn Supramol, F-70028 Strasbourg, France
[2] Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland
[3] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA
基金
美国国家卫生研究院;
关键词
binding free energy estimation; continuum electrostatics; drug design; HIV-1; protease; LIE method; ligand binding;
D O I
10.1023/B:JCAM.0000021882.99270.4c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A method is proposed for the estimation of absolute binding free energy of interaction between proteins and ligands. Conformational sampling of the protein-ligand complex is performed by molecular dynamics ( MD) in vacuo and the solvent effect is calculated a posteriori by solving the Poisson or the Poisson-Boltzmann equation for selected frames of the trajectory. The binding free energy is written as a linear combination of the buried surface upon complexation, SAS(bur), the electrostatic interaction energy between the ligand and the protein, E-elec, and the difference of the solvation free energies of the complex and the isolated ligand and protein, DeltaG(solv). The method uses the buried surface upon complexation to account for the non-polar contribution to the binding free energy because it is less sensitive to the details of the structure than the van der Waals interaction energy. The parameters of the method are developed for a training set of 16 HIV-1 protease-inhibitor complexes of known 3D structure. A correlation coefficient of 0.91 was obtained with an unsigned mean error of 0.8 kcal/mol. When applied to a set of 25 HIV-1 protease-inhibitor complexes of unknown 3D structures, the method provides a satisfactory correlation between the calculated binding free energy and the experimental pIC(50) without reparametrization.
引用
收藏
页码:861 / 880
页数:20
相关论文
共 99 条
[1]   INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRICAL PHOSPHINATE - SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS [J].
ABDELMEGUID, SS ;
ZHAO, BG ;
MURTHY, KHM ;
WINBORNE, E ;
CHOI, JK ;
DESJARLAIS, RL ;
MINNICH, MD ;
CULP, JS ;
DEBOUCK, C ;
TOMASZEK, TA ;
MEEK, TD ;
DREYER, GB .
BIOCHEMISTRY, 1993, 32 (31) :7972-7980
[2]  
AJAY MMA, 1995, J MED CHEM, V38, P4953
[3]  
Aqvist J, 1996, J COMPUT CHEM, V17, P1587, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO
[4]  
2-H
[5]   NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN [J].
AQVIST, J ;
MEDINA, C ;
SAMUELSSON, JE .
PROTEIN ENGINEERING, 1994, 7 (03) :385-391
[6]   Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase [J].
Archontis, G ;
Simonson, T ;
Karplus, M .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 306 (02) :307-327
[7]   Cumulant expansion of the free energy: Application to free energy derivatives and component analysis [J].
Archontis, G ;
Karplus, M .
JOURNAL OF CHEMICAL PHYSICS, 1996, 105 (24) :11246-11260
[8]   STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
LIU, BS ;
TOPOL, IA ;
KISO, Y ;
MIMOTO, T ;
MITSUYA, H ;
ERICKSON, JW .
STRUCTURE, 1995, 3 (06) :581-590
[9]   Structure-based thermodynamic analysis of HIV-1 protease inhibitors [J].
Bardi, JS ;
Luque, I ;
Freire, E .
BIOCHEMISTRY, 1997, 36 (22) :6588-6596
[10]   Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs [J].
Bohm, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (04) :309-323